Table 4.
Success of two-stage revision TKA
| Study | Year published | Number of successful patients (%) | Mean followup (months) | Resistant organism (%) | Definition of failure |
|---|---|---|---|---|---|
| Insall et al. [28] | 1983 | 10/11 (91) | 34 | NR | Recurrence of infection |
| Wilde and Ruth [49] | 1988 | 9/10 (90) | 33 | NR | Recurrence of infection |
| Booth and Lotke [2] | 1989 | 24/25 (96) | 25 | NR | Recurrence of infection |
| Teeny et al. [48] | 1990 | 10/10 (100) | 42.5 | NR | Recurrence of infection |
| Wilson et al. [50] | 1990 | 16/20 (80) | 34 | NR | Recurrence of infection |
| Masri et al. [36] | 1994 | 22/24 (92) | 26 | NR | Recurrence of infection |
| Goldman et al. [15] | 1996 | 58/64 (91) | 90 | NR | Recurrence of infection |
| Hirakawa et al. [24] | 1998 | 41/55 (75) | 62 | 11 | Recurrence of infection |
| Fehring et al. [13] | 2000 | 51/55 (93) | 36 | NR | Recurrence of infection |
| Durbhakula et al. [12] | 2004 | 22/24 (92) | 33 | 20 | Recurrence of infection |
| Haleem et al. [18] | 2004 | 87/96 (91) | 86 | NR | Recurrence of infection |
| Cuckler [9] | 2005 | 43/44 (98) | NR | 11 | Recurrence of infection |
| Hoffman et al. [26] | 2005 | 44/50 (88) | 30 | 4 | Recurrence of infection |
| Hart and Jones [22] | 2006 | 42/48 (88) | 48.5 | 2 | Recurrence of infection |
| Kurd et al. [32] | 2010 | 70/96 (73) | 34.5 | 50 | Recurrence of infection |
| Mahmud et al. [current study] | 2012 | 220/236 (93) | 48 | 4 | Recurrence of infection |
NR = not recorded.